• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黏多糖贮积症VI型临床谱系衰减端的索引病例。

An index case for the attenuated end of the mucopolysaccharidosis type VI clinical spectrum.

作者信息

Brooks Doug A, Gibson Gary J, Karageorgos Litsa, Hein Leanne K, Robertson Evelyn F, Hopwood John J

机构信息

Lysosomal Diseases Research Unit, Department of Genetic Medicine, Women's and Children's Hospital, North Adelaide, SA 5006, Australia.

出版信息

Mol Genet Metab. 2005 Jul;85(3):236-8. doi: 10.1016/j.ymgme.2005.02.008. Epub 2005 Mar 24.

DOI:10.1016/j.ymgme.2005.02.008
PMID:15979036
Abstract

Mucopolysaccharidosis type VI (MPS VI, Maroteaux-Lamy syndrome, McKusick #253200) is a lysosomal storage disorder that is caused by a deficiency in the lysosomal exohydrolase N-acetylgalactosamine-4-sulphatase (4-sulphatase, EC 3.1.6.1). We report a patient with no obvious clinical signs of MPS VI that has 5% of normal 4-sulphatase catalytic capacity. This patient represents an index case for the attenuated end of the MPS VI clinical spectrum.

摘要

黏多糖贮积症VI型(MPS VI,马罗-拉米综合征,麦库西克编号#253200)是一种溶酶体贮积病,由溶酶体外切糖苷酶N-乙酰半乳糖胺-4-硫酸酯酶(4-硫酸酯酶,EC 3.1.6.1)缺乏所致。我们报告了一名无明显MPS VI临床症状的患者,其4-硫酸酯酶催化能力为正常水平的5%。该患者代表了MPS VI临床谱减弱端的首例病例。

相似文献

1
An index case for the attenuated end of the mucopolysaccharidosis type VI clinical spectrum.黏多糖贮积症VI型临床谱系衰减端的索引病例。
Mol Genet Metab. 2005 Jul;85(3):236-8. doi: 10.1016/j.ymgme.2005.02.008. Epub 2005 Mar 24.
2
Mutational analysis of 105 mucopolysaccharidosis type VI patients.105例VI型黏多糖贮积症患者的突变分析
Hum Mutat. 2007 Sep;28(9):897-903. doi: 10.1002/humu.20534.
3
Mucopolysaccharidosis type VI: Structural and clinical implications of mutations in N-acetylgalactosamine-4-sulfatase.VI型黏多糖贮积症:N-乙酰半乳糖胺-4-硫酸酯酶突变的结构和临床意义
Hum Mutat. 2001 Oct;18(4):282-95. doi: 10.1002/humu.1190.
4
Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): a Y210C mutation causes either altered protein handling or altered protein function of N-acetylgalactosamine 4-sulfatase at multiple points in the vacuolar network.黏多糖贮积症VI型(马罗-拉米综合征):Y210C突变导致N-乙酰半乳糖胺4-硫酸酯酶在液泡网络的多个位点出现蛋白处理改变或蛋白功能改变。
Biochemistry. 2002 Apr 16;41(15):4962-71. doi: 10.1021/bi0121149.
5
Genetic analysis of mucopolysaccharidosis type VI in Taiwanese patients.台湾黏多糖贮积症VI型患者的基因分析。
Clin Chim Acta. 2008 Aug;394(1-2):89-93. doi: 10.1016/j.cca.2008.04.014. Epub 2008 Apr 27.
6
Identification of the molecular defects in Spanish and Argentinian mucopolysaccharidosis VI (Maroteaux-Lamy syndrome) patients, including 9 novel mutations.西班牙和阿根廷黏多糖贮积症VI型(马罗托-拉米综合征)患者分子缺陷的鉴定,包括9种新突变。
Mol Genet Metab. 2007 Sep-Oct;92(1-2):122-30. doi: 10.1016/j.ymgme.2007.06.002. Epub 2007 Jul 20.
7
An N-acetylgalactosamine-4-sulfatase mutation (delta G238) results in a severe Maroteaux-Lamy phenotype.一种N-乙酰半乳糖胺-4-硫酸酯酶突变(δG238)导致严重的马罗-拉米表型。
Hum Mutat. 1992;1(5):397-402. doi: 10.1002/humu.1380010509.
8
Novel Mutations, Including a Large Deletion in the ARSB Gene, Causing Mucopolysaccharidosis Type VI.新型突变,包括ARSB基因的大片段缺失,导致VI型黏多糖贮积症。
Genet Test Mol Biomarkers. 2017 Jan;21(1):58-62. doi: 10.1089/gtmb.2016.0221. Epub 2016 Oct 31.
9
Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase.黏多糖贮积症 VI 型(马罗托-拉米综合征)酶替代治疗期间耐力、活动能力和关节功能指标的直接比较:重组人 N-乙酰半乳糖胺 4-硫酸酯酶 2 期开放标签临床研究 48 周后的结果
Pediatrics. 2005 Jun;115(6):e681-9. doi: 10.1542/peds.2004-1023.
10
Identification of arylsulfatase B gene mutations and clinical presentations of Iranian patients with Mucopolysaccharidosis VI.鉴定伊朗黏多糖贮积症 VI 型患者的芳基硫酸酯酶 B 基因突变与临床表现。
Gene. 2019 Jul 20;706:1-5. doi: 10.1016/j.gene.2019.04.050. Epub 2019 Apr 19.

引用本文的文献

1
Mucopolysaccharidosis Type VI, an Updated Overview of the Disease.黏多糖贮积症 VI 型:疾病的最新概述。
Int J Mol Sci. 2021 Dec 15;22(24):13456. doi: 10.3390/ijms222413456.
2
Identification of eleven different mutations including six novel, in the arylsulfatase B gene in Iranian patients with mucopolysaccharidosis type VI.在伊朗黏多糖贮积症 VI 型患者的芳基硫酸酯酶 B 基因中鉴定出十一种不同的突变,包括六种新突变。
Mol Biol Rep. 2019 Jun;46(3):3417-3426. doi: 10.1007/s11033-019-04804-9. Epub 2019 Apr 13.
3
Mucopolysaccharidosis Type VI in a Great Dane Caused by a Nonsense Mutation in the ARSB Gene.
一只大丹犬因ARSB基因的无义突变导致的VI型黏多糖贮积症。
Vet Pathol. 2018 Mar;55(2):286-293. doi: 10.1177/0300985817732115. Epub 2017 Nov 20.
4
Evaluation of oral manifestations of patients with mucopolysaccharidosis IV and VI: clinical and imaging study.评估黏多糖贮积症 IV 型和 VI 型患者的口腔表现:临床和影像学研究。
Clin Oral Investig. 2018 Jan;22(1):201-208. doi: 10.1007/s00784-017-2100-8. Epub 2017 Mar 19.
5
Discovery and functional prioritization of Parkinson's disease candidate genes from large-scale whole exome sequencing.通过大规模全外显子组测序发现帕金森病候选基因并进行功能优先级排序。
Genome Biol. 2017 Jan 30;18(1):22. doi: 10.1186/s13059-017-1147-9.
6
Diagnostic and treatment strategies in mucopolysaccharidosis VI.黏多糖贮积症VI型的诊断与治疗策略
Appl Clin Genet. 2015 Oct 30;8:245-55. doi: 10.2147/TACG.S68650. eCollection 2015.
7
Prevalence of anti-adeno-associated virus serotype 8 neutralizing antibodies and arylsulfatase B cross-reactive immunologic material in mucopolysaccharidosis VI patient candidates for a gene therapy trial.黏多糖贮积症VI型患者中抗8型腺相关病毒中和抗体及芳基硫酸酯酶B交叉反应性免疫物质的流行情况,这些患者是基因治疗试验的候选对象。
Hum Gene Ther. 2015 Mar;26(3):145-52. doi: 10.1089/hum.2014.109.
8
First report of c. 1499G>C mutation in a 6-month-child with cystic fibrosis.一名6个月大的囊性纤维化患儿中c. 1499G>C突变的首次报告。
Indian J Hum Genet. 2014 Apr;20(2):199-202. doi: 10.4103/0971-6866.142911.
9
Attenuated osteoarticular phenotype of type VI mucopolysaccharidosis: a report of four patients and a review of the literature.VI型黏多糖贮积症的骨关节表型减轻:4例患者报告及文献复习
Clin Rheumatol. 2014 May;33(5):725-31. doi: 10.1007/s10067-013-2423-z. Epub 2013 Nov 13.
10
Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management.黏多糖贮积症患者的心脏疾病:临床表现、诊断与治疗。
J Inherit Metab Dis. 2011 Dec;34(6):1183-97. doi: 10.1007/s10545-011-9359-8. Epub 2011 Jul 9.